These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 12953261

  • 1. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons.
    Keswani SC, Polley M, Pardo CA, Griffin JW, McArthur JC, Hoke A.
    Ann Neurol; 2003 Sep; 54(3):287-96. PubMed ID: 12953261
    [Abstract] [Full Text] [Related]

  • 2. Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy.
    Melli G, Keswani SC, Fischer A, Chen W, Höke A.
    Brain; 2006 May; 129(Pt 5):1330-8. PubMed ID: 16537566
    [Abstract] [Full Text] [Related]

  • 3. The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons.
    Apostolski S, McAlarney T, Quattrini A, Levison SW, Rosoklija G, Lugaressi A, Corbo M, Sadiq SA, Lederman S, Hays AP.
    Ann Neurol; 1993 Dec; 34(6):855-63. PubMed ID: 8250536
    [Abstract] [Full Text] [Related]

  • 4. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
    Nosheny RL, Bachis A, Aden SA, De Bernardi MA, Mocchetti I.
    J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
    [Abstract] [Full Text] [Related]

  • 5. Semisynthetic sphingoglycolipid LIGA20 is neuroprotective against human immunodeficiency virus-gp120-mediated apoptosis.
    Bachis A, Mocchetti I.
    J Neurosci Res; 2006 Apr; 83(5):890-6. PubMed ID: 16477610
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system].
    Merino JJ, Montes ML, Blanco A, Bustos MJ, Oreja-Guevara C, Bayon C, Cuadrado A, Lubrini G, Cambron I, Munoz A, Cebolla S, Gutierrez-Fernandez M, Bernardino JI, Arribas JR, Fiala M.
    Rev Neurol; 2011 Jan 16; 52(2):101-11. PubMed ID: 21271550
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
    Louboutin JP, Agrawal L, Reyes BA, Van Bockstaele EJ, Strayer DS.
    Gene Ther; 2007 Dec 16; 14(23):1650-61. PubMed ID: 17914406
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.